Yamamoto H, Soh J, Okumura N, Suzuki H, et al. Randomized phase II study of daily versus alternate-day administrations of S-1
for the elderly patients with completely resected pathological stage IA (tumor
diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group
Study 1201. PLoS One 2023;18:e0285273.
PMID: 37205678